-

Hologic Receives Gallup Exceptional Workplace Award

-- First Time Named to Top List of Highly Engaged Companies --

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has been named a winner of the 2021 Gallup Exceptional Workplace Award, the Company announced today. This prestigious award recognizes the most engaged workplace cultures in the world.

Hologic has been on a six-year journey to create a culture of high engagement by focusing on developing talent, transforming its talent acquisition and succession practices, and ultimately driving performance. Throughout this cultural transformation, Hologic has put engagement at the heart of its business strategies. Since 2015, Hologic has moved from the 36th percentile of Gallup’s company engagement database to the 96th percentile compared to peer organizations.

“In 2020, organizational cultures saw historic threats,” said Jim Harter, Gallup’s chief scientist of workplace management and wellbeing. “It took an exceptional amount of resilience for organizations, and their employees, to make it through. The abundance of well-managed and highly inspired teams inside Gallup Exceptional Workplace Award-winning organizations put them in a particularly strong position to adapt quickly to meet the needs of their customers and patients.”

The Gallup Exceptional Workplace Award recognizes Hologic’s steady, disciplined commitment to engagement, which fueled its COVID-19 response over the past year. “In 2020, our leaders united around the belief that ‘tough times reveal character,’” said Ali Bebo, senior vice president of human resources, Hologic. “The way we treated our employees in the early days of the pandemic set the stage for the incredible contributions they made, and will continue contributing to strong performance in the future.”

Hologic earned this top distinction having met established quantitative criteria and a comprehensive qualitative evaluation examining how the Company ranks against employers that together hire millions of people around the globe.

“Even as we recognize the tremendous progress we’ve made, we know there is still work to be done,” said Steve MacMillan, chairman, president and chief executive officer, Hologic. “We are on a journey to have the greatest impact through the Science of Sure, and we will keep setting the bar higher. We will not be satisfied until every employee at Hologic has a great manager, is surrounded by engaged colleagues, and is empowered to deliver their best every day.”

Gallup’s comprehensive analysis shows that highly engaged organizations significantly outperform their peers in important business outcomes, including customer ratings, profitability, productivity, turnover, safety incidents, shrinkage, absenteeism, quality, employee well-being, and organizational citizenship.

For a full list of recipients, please see here.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

Hologic and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

Forward Looking Statements

This news release may contain forward-looking information that involves risks and uncertainties, including statements about the Company’s plans, objectives, expectations and intentions. There can be no assurance that these efforts will be successful, benefit the Company and its stockholders, or improve over time. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any changes in expectations or events, conditions or circumstances on which any such data or statements are based.

Source: Hologic, Inc.

Contacts

Investor Contact
Michael Watts
Vice President, Investor Relations and Corporate Communications
(858) 410-8588
michael.watts@hologic.com

Media Contact
Jane Mazur
Vice President, Divisional Communications
(585) 355-5978
jane.mazur@hologic.com

Hologic, Inc.

NASDAQ:HOLX

Release Summary
Hologic Receives Gallup Exceptional Workplace Award
Release Versions

Contacts

Investor Contact
Michael Watts
Vice President, Investor Relations and Corporate Communications
(858) 410-8588
michael.watts@hologic.com

Media Contact
Jane Mazur
Vice President, Divisional Communications
(585) 355-5978
jane.mazur@hologic.com

More News From Hologic, Inc.

CE-IVDR Mark for Hologic’s Aptima® HPV Test Expanded to Include Self-Collected Sample Claim in Cervical Cancer Screening

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. announced today that its Aptima® HPV Assay received an expanded CE-IVDR marking in the European Union and the UK and is now approved for self-collected vaginal samples using the Aptima Multitest Specimen Collection Kit. Cervical cancer is the fourth most common cancer in women but is largely preventable through HPV vaccination and regular screening.1 Evidence shows that organized screening and early detection reduces deaths from cervical cancer...

Hologic’s New Sustainability Report Marks 40 Years of Impact

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc., a global leader in women’s health, today released its 2025 Sustainability Report. The new report coincides with Hologic’s 40th anniversary and underscores how the company’s longstanding purpose — to enable healthier lives for women everywhere, every day — continues to drive progress for patients, communities and the planet. “We have always firmly believed that our success as a company is fundamentally tied to our ability and commitment to help...

Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. today announced a significant and far-reaching victory in the Unified Patent Court (UPC) in Germany, which ruled that Siemens* infringed upon a critical Hologic mammography technology patent in Siemens’ latest mammography system. The court imposed a sweeping injunction, immediately prohibiting Siemens from making, offering, placing on the market, using or importing or storing for those purposes its MAMMOMAT B.brilliant systems across Germany, F...
Back to Newsroom